Integrated Diagnostics Holdings PLC (IDHC) — Capital Reinvestment Ratio
Integrated Diagnostics Holdings PLC (IDHC) has a Capital Reinvestment Ratio of 0.29x as of June 2025, meaning it reinvests 0% of its operating cash flow ($197.02 Million) in capital expenditures ($56.40 Million). See IDHC equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Integrated Diagnostics Holdings PLC Capital Reinvestment Ratio (2012–2024)
This chart tracks Integrated Diagnostics Holdings PLC's Capital Reinvestment Ratio across 13 annual periods. Check Integrated Diagnostics Holdings PLC (IDHC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC (2012–2024)
Year-by-year Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC from 2012 to 2024. For live market cap and broader valuation context, see Integrated Diagnostics Holdings PLC stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | $1.57 Billion | $224.60 Million | ▼ -76.1% |
| 2023 | 0.60x | $543.66 Million | $325.93 Million | ▼ -59.5% |
| 2022 | 1.48x | $208.73 Million | $308.84 Million | ▲ +1173.4% |
| 2021 | 0.12x | $2.27 Billion | $263.74 Million | ▼ -18.6% |
| 2020 | 0.14x | $882.51 Million | $126.01 Million | ▼ -54.3% |
| 2019 | 0.31x | $697.41 Million | $218.00 Million | ▼ -47.6% |
| 2018 | 0.60x | $556.31 Million | $331.55 Million | ▲ +52.7% |
| 2017 | 0.39x | $403.07 Million | $157.35 Million | ▲ +220.6% |
| 2016 | 0.12x | $398.66 Million | $48.54 Million | ▼ -57.9% |
| 2015 | 0.29x | $189.86 Million | $54.90 Million | ▲ +14.6% |
| 2014 | 0.25x | $301.59 Million | $76.09 Million | ▲ +111.5% |
| 2013 | 0.12x | $209.29 Million | $24.97 Million | ▲ +196.8% |
| 2012 | 0.04x | $639.10 Million | $25.69 Million | — |